Skip to main content

17.05.2024 | Original Article

Association of dietary iron intake with diabetic kidney disease among individuals with diabetes

verfasst von: Yichuan Wu, Manlu Xiao, Jiaqi Chen, Yuan Tao, Aomiao Chen, Huanjia Lin, Ying Xu, Linna Li, Hongxia Jia, Yaoming Xue, Yijie Jia, Zongji Zheng

Erschienen in: Endocrine

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The current study investigated the correlation between dietary iron intake and diabetic kidney disease among diabetic adults.

Methods

This cross-sectional study enrolled 8118 participants who suffered from diabetes from the National Health and Nutrition Examination Survey (NHANES) 1999–2018. Dietary iron intake was obtained from 24 h recall interviews, and diabetic kidney disease was defined as eGFR < 60 mL/min per 1.73 m2 or albumin creatinine ratio (ACR) ≥ 30 mg/g. Three weighted logistic regression models were utilized to investigate odd ratio (OR) and 95% CIs for diabetic kidney disease. Stratified analyses were performed by gender, age, BMI, HbA1c, hypertension status, and smoking status, and diabetes types.

Results

Among 8118 participants (51.6% male, mean age 61.3 years), 40.7% of participants suffered from diabetic kidney disease. With the adjustment of potential covariates, we found that ≥ 12.59 mg of dietary iron was related to a lower risk of diabetic kidney disease (OR = 0.78, 95% CI: 0.63 to 0.96; OR = 0.79, 95% CI: 0.63 to 0.98). In stratified analyses, higher iron intake was negatively related to diabetic kidney disease, especially among those who were male, < 60 years, those with hypertension, those with HbA1c < 7.0%, and those who were ex-smokers. The result remained robust in sensitivity analyses.

Conclusion

We found that ≥ 12.59 mg of dietary iron is associated with a lower risk of diabetic kidney disease, especially in those who were male, younger, heavier weight, have better blood sugar control, and those who were ex-smokers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat M.K. Ali, J. Pearson-Stuttard, E. Selvin, E.W. Gregg, Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia 65, 3–13 (2022)CrossRefPubMed M.K. Ali, J. Pearson-Stuttard, E. Selvin, E.W. Gregg, Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia 65, 3–13 (2022)CrossRefPubMed
2.
Zurück zum Zitat M. Neuenschwander, A. Ballon, K.S. Weber, T. Norat, D. Aune, L. Schwingshackl, S. Schlesinger, Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ 366, l2368 (2019)CrossRefPubMedPubMedCentral M. Neuenschwander, A. Ballon, K.S. Weber, T. Norat, D. Aune, L. Schwingshackl, S. Schlesinger, Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ 366, l2368 (2019)CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat J. He, A. Fang, S. Yu, X. Shen, K. Li, Dietary Nonheme, Heme, and total iron intake and the risk of diabetes in adults: results from the china health and nutrition survey. Diabetes Care 43, 776–784 (2020)CrossRefPubMedPubMedCentral J. He, A. Fang, S. Yu, X. Shen, K. Li, Dietary Nonheme, Heme, and total iron intake and the risk of diabetes in adults: results from the china health and nutrition survey. Diabetes Care 43, 776–784 (2020)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Z. Shi, X. Hu, B. Yuan, X. Pan, H.E. Meyer, G. Holmboe-Ottesen, Association between serum ferritin, hemoglobin, iron intake, and diabetes in adults in Jiangsu, China. Diabetes Care 29, 1878–1883 (2006)CrossRefPubMed Z. Shi, X. Hu, B. Yuan, X. Pan, H.E. Meyer, G. Holmboe-Ottesen, Association between serum ferritin, hemoglobin, iron intake, and diabetes in adults in Jiangsu, China. Diabetes Care 29, 1878–1883 (2006)CrossRefPubMed
6.
Zurück zum Zitat X. Wang, X. Fang, W. Zheng, J. Zhou, Z. Song, M. Xu, J. Min, F. Wang, Genetic support of a causal relationship between iron status and Type 2 diabetes: a mendelian randomization study. J. Clin. Endocrinol. Metab. 106, e4641–e4651 (2021)CrossRefPubMedPubMedCentral X. Wang, X. Fang, W. Zheng, J. Zhou, Z. Song, M. Xu, J. Min, F. Wang, Genetic support of a causal relationship between iron status and Type 2 diabetes: a mendelian randomization study. J. Clin. Endocrinol. Metab. 106, e4641–e4651 (2021)CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Y. Huang, D. Cao, Z. Chen, B. Chen, J. Li, R. Wang, J. Guo, Q. Dong, C. Liu, Q. Wei, L. Liu, Iron intake and multiple health outcomes: umbrella review. Crit. Rev. Food Sci. 63, 2910–2927 (2023).CrossRef Y. Huang, D. Cao, Z. Chen, B. Chen, J. Li, R. Wang, J. Guo, Q. Dong, C. Liu, Q. Wei, L. Liu, Iron intake and multiple health outcomes: umbrella review. Crit. Rev. Food Sci. 63, 2910–2927 (2023).CrossRef
8.
Zurück zum Zitat S. Rajpathak, J. Ma, J. Manson, W.C. Willett, F.B. Hu, Iron intake and the risk of type 2 diabetes in women: a prospective cohort study. Diabetes Care 29, 1370–1376 (2006)CrossRefPubMed S. Rajpathak, J. Ma, J. Manson, W.C. Willett, F.B. Hu, Iron intake and the risk of type 2 diabetes in women: a prospective cohort study. Diabetes Care 29, 1370–1376 (2006)CrossRefPubMed
9.
Zurück zum Zitat A. Reunanen, H. Takkunen, P. Knekt, R. Seppänen, A. Aromaa, Body iron stores, dietary iron intake and coronary heart disease mortality. J. Intern. Med. 238, 223–230 (1995)CrossRefPubMed A. Reunanen, H. Takkunen, P. Knekt, R. Seppänen, A. Aromaa, Body iron stores, dietary iron intake and coronary heart disease mortality. J. Intern. Med. 238, 223–230 (1995)CrossRefPubMed
10.
Zurück zum Zitat A.G.R. Mainous, B. Wells, P.J. Carek, J.M. Gill, M.E. Geesey, The mortality risk of elevated serum transferrin saturation and consumption of dietary iron. Ann. Fam. Med. 2, 139–144 (2004)CrossRefPubMedPubMedCentral A.G.R. Mainous, B. Wells, P.J. Carek, J.M. Gill, M.E. Geesey, The mortality risk of elevated serum transferrin saturation and consumption of dietary iron. Ann. Fam. Med. 2, 139–144 (2004)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Johnson C.L., Paulose-Ram R., Ogden C.L., Carroll M.D., Kruszon-Moran D., Dohrmann S.M., Curtin L.R. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat. Series 2 161, 1–24 (2013) Johnson C.L., Paulose-Ram R., Ogden C.L., Carroll M.D., Kruszon-Moran D., Dohrmann S.M., Curtin L.R. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat. Series 2 161, 1–24 (2013)
12.
Zurück zum Zitat Zipf G., Chiappa M., Porter K.S., Ostchega Y., Lewis B.G., Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat. Ser. 1, Program Collection Procedures 56, 1–37 (2013) Zipf G., Chiappa M., Porter K.S., Ostchega Y., Lewis B.G., Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat. Ser. 1, Program Collection Procedures 56, 1–37 (2013)
13.
Zurück zum Zitat A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.R. Castro, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh, A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009)CrossRefPubMedPubMedCentral A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.R. Castro, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh, A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009)CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat I.H. de Boer, K. Khunti, T. Sadusky, K.R. Tuttle, J.J. Neumiller, C.M. Rhee, S.E. Rosas, P. Rossing, G. Bakris, Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 102, 974–989 (2022)CrossRefPubMed I.H. de Boer, K. Khunti, T. Sadusky, K.R. Tuttle, J.J. Neumiller, C.M. Rhee, S.E. Rosas, P. Rossing, G. Bakris, Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 102, 974–989 (2022)CrossRefPubMed
15.
Zurück zum Zitat S.C. DeShields, T.D. Cunningham, Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus. J. Endocrinol. Investig. 41, 1051–1060 (2018)CrossRef S.C. DeShields, T.D. Cunningham, Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus. J. Endocrinol. Investig. 41, 1051–1060 (2018)CrossRef
16.
Zurück zum Zitat Johnson C.L., Paulose-Ram R., Ogden C.L., Carroll M.D., Kruszon-Moran D., Dohrmann S.M., Curtin L.R.: National health and nutrition examination survey: analytic guidelines, 1999-2010. Vital and health statistics. Series 2, Data Evaluation and Methods Research:1-24 (2013) Johnson C.L., Paulose-Ram R., Ogden C.L., Carroll M.D., Kruszon-Moran D., Dohrmann S.M., Curtin L.R.: National health and nutrition examination survey: analytic guidelines, 1999-2010. Vital and health statistics. Series 2, Data Evaluation and Methods Research:1-24 (2013)
17.
Zurück zum Zitat P. Trumbo, A.A. Yates, S. Schlicker, M. Poos, Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J. Am. Diet. Assoc. 101, 294–301 (2001)CrossRefPubMed P. Trumbo, A.A. Yates, S. Schlicker, M. Poos, Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J. Am. Diet. Assoc. 101, 294–301 (2001)CrossRefPubMed
18.
Zurück zum Zitat D. Hirano, H. Unoki-Kubota, T. Imasawa, R. Yamamoto-Honda, H. Kajio, S. Yamashita, Y. Fukazawa, N. Seki, M. Noda, Y. Kaburagi, Independent risk factors of rapid glomerular filtration rate decline in patients with type 2 diabetes with preserved kidney function and normoalbuminuria: a multicenter cohort study. J. Diabetes Investig. 14, 874–882 (2023).CrossRefPubMedPubMedCentral D. Hirano, H. Unoki-Kubota, T. Imasawa, R. Yamamoto-Honda, H. Kajio, S. Yamashita, Y. Fukazawa, N. Seki, M. Noda, Y. Kaburagi, Independent risk factors of rapid glomerular filtration rate decline in patients with type 2 diabetes with preserved kidney function and normoalbuminuria: a multicenter cohort study. J. Diabetes Investig. 14, 874–882 (2023).CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat S.D. Mathias, S.I. Blum, V. Sikirica, K.L. Johansen, H.H. Colwell, T. Okoro, Symptoms and impacts in anemia of chronic kidney disease. J. Patient Rep. Outcom 4, 64 (2020)CrossRef S.D. Mathias, S.I. Blum, V. Sikirica, K.L. Johansen, H.H. Colwell, T. Okoro, Symptoms and impacts in anemia of chronic kidney disease. J. Patient Rep. Outcom 4, 64 (2020)CrossRef
20.
Zurück zum Zitat A.R. Hizomi, F. Fakhri, T.M. Naeimi, F. Talebi, Z. Talebi, N. Rashidi, M. Zahedi, Prevalence of anemia and its associated factors among patients with type 2 diabetes mellitus in a referral diabetic clinic in the north of Iran. Bmc Endocr. Disord. 23, 58 (2023)CrossRef A.R. Hizomi, F. Fakhri, T.M. Naeimi, F. Talebi, Z. Talebi, N. Rashidi, M. Zahedi, Prevalence of anemia and its associated factors among patients with type 2 diabetes mellitus in a referral diabetic clinic in the north of Iran. Bmc Endocr. Disord. 23, 58 (2023)CrossRef
21.
Zurück zum Zitat Y. Wu, Y. Sun, Y. Wu, K. Zhang, Y. Chen, Predictive value of ferroptosis-related biomarkers for diabetic kidney disease: a prospective observational study. Acta Diabetol. 60, 507–516 (2023)CrossRefPubMedPubMedCentral Y. Wu, Y. Sun, Y. Wu, K. Zhang, Y. Chen, Predictive value of ferroptosis-related biomarkers for diabetic kidney disease: a prospective observational study. Acta Diabetol. 60, 507–516 (2023)CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat M. Mo, Y. Gao, L. Deng, Y. Liang, N. Xia, L. Pan, Association between iron metabolism and acute kidney injury in critically Ill patients with diabetes. Front. Endocrinol. 13, 892811 (2022)CrossRef M. Mo, Y. Gao, L. Deng, Y. Liang, N. Xia, L. Pan, Association between iron metabolism and acute kidney injury in critically Ill patients with diabetes. Front. Endocrinol. 13, 892811 (2022)CrossRef
24.
Zurück zum Zitat M.C.F.D. Santos, C.P. Anderson, S. Neschen, K.B. Zumbrennen-Bullough, S.J. Romney, M. Kahle-Stephan, B. Rathkolb, V. Gailus-Durner, H. Fuchs, E. Wolf, J. Rozman, M.H. de Angelis, W.M. Cai, M. Rajan, J. Hu, P.C. Dedon, E.A. Leibold, Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification. Nat. Commun. 11, 296 (2020)CrossRefPubMedPubMedCentral M.C.F.D. Santos, C.P. Anderson, S. Neschen, K.B. Zumbrennen-Bullough, S.J. Romney, M. Kahle-Stephan, B. Rathkolb, V. Gailus-Durner, H. Fuchs, E. Wolf, J. Rozman, M.H. de Angelis, W.M. Cai, M. Rajan, J. Hu, P.C. Dedon, E.A. Leibold, Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification. Nat. Commun. 11, 296 (2020)CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat M. Yamanouchi, K. Furuichi, M. Shimizu, T. Toyama, Y. Yamamura, M. Oshima, S. Kitajima, A. Hara, Y. Iwata, N. Sakai, Y. Oba, S. Matsuoka, D. Ikuma, H. Mizuno, T. Suwabe, J. Hoshino, N. Sawa, Y. Yuzawa, H. Kitamura, Y. Suzuki, H. Sato, N. Uesugi, Y. Ueda, S. Nishi, H. Yokoyama, T. Nishino, K. Samejima, K. Kohagura, Y. Shibagaki, H. Makino, S. Matsuo, Y. Ubara, T. Wada, Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study. Nephrol. Dial. Transpl. 37, 489–497 (2022)CrossRef M. Yamanouchi, K. Furuichi, M. Shimizu, T. Toyama, Y. Yamamura, M. Oshima, S. Kitajima, A. Hara, Y. Iwata, N. Sakai, Y. Oba, S. Matsuoka, D. Ikuma, H. Mizuno, T. Suwabe, J. Hoshino, N. Sawa, Y. Yuzawa, H. Kitamura, Y. Suzuki, H. Sato, N. Uesugi, Y. Ueda, S. Nishi, H. Yokoyama, T. Nishino, K. Samejima, K. Kohagura, Y. Shibagaki, H. Makino, S. Matsuo, Y. Ubara, T. Wada, Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study. Nephrol. Dial. Transpl. 37, 489–497 (2022)CrossRef
26.
Zurück zum Zitat P.J. Thompson, A. Shah, V. Ntranos, F. Van Gool, M. Atkinson, A. Bhushan, Targeted elimination of senescent beta cells prevents Type 1 Diabetes. Cell Metab. 29, 1045–1060 (2019)CrossRefPubMed P.J. Thompson, A. Shah, V. Ntranos, F. Van Gool, M. Atkinson, A. Bhushan, Targeted elimination of senescent beta cells prevents Type 1 Diabetes. Cell Metab. 29, 1045–1060 (2019)CrossRefPubMed
27.
Zurück zum Zitat Y. Wu, Y. Zhao, H.Z. Yang, Y.J. Wang, Y. Chen, HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose. Biosci. Rep. 41, BSR20202924 (2021)CrossRefPubMedPubMedCentral Y. Wu, Y. Zhao, H.Z. Yang, Y.J. Wang, Y. Chen, HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose. Biosci. Rep. 41, BSR20202924 (2021)CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat A. Aregbesola, S. Voutilainen, J.K. Virtanen, J. Mursu, T.P. Tuomainen, Gender difference in type 2 diabetes and the role of body iron stores. Ann. Clin. Biochem. 54, 113–120 (2017)CrossRefPubMed A. Aregbesola, S. Voutilainen, J.K. Virtanen, J. Mursu, T.P. Tuomainen, Gender difference in type 2 diabetes and the role of body iron stores. Ann. Clin. Biochem. 54, 113–120 (2017)CrossRefPubMed
29.
Zurück zum Zitat L.R. Zacharski, D.L. Ornstein, S. Woloshin, L.M. Schwartz, Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am. Heart J. 140, 98–104 (2000)CrossRefPubMed L.R. Zacharski, D.L. Ornstein, S. Woloshin, L.M. Schwartz, Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am. Heart J. 140, 98–104 (2000)CrossRefPubMed
30.
Zurück zum Zitat K.T. Grubic, B. Curko-Cofek, Age-related changes and sex-related differences in brain iron metabolism. Nutrients 12, 2601 (2020).CrossRef K.T. Grubic, B. Curko-Cofek, Age-related changes and sex-related differences in brain iron metabolism. Nutrients 12, 2601 (2020).CrossRef
31.
Zurück zum Zitat C. Vecchi, G. Montosi, C. Garuti, E. Corradini, M. Sabelli, S. Canali, A. Pietrangelo, Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Gastroenterology 146, 1060–1069 (2014)CrossRefPubMed C. Vecchi, G. Montosi, C. Garuti, E. Corradini, M. Sabelli, S. Canali, A. Pietrangelo, Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Gastroenterology 146, 1060–1069 (2014)CrossRefPubMed
32.
Zurück zum Zitat J.M. Fernandez-Real, D. McClain, M. Manco, Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes. Diabetes Care 38, 2169–2176 (2015)CrossRefPubMed J.M. Fernandez-Real, D. McClain, M. Manco, Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes. Diabetes Care 38, 2169–2176 (2015)CrossRefPubMed
33.
Zurück zum Zitat P. Krisai, S. Leib, S. Aeschbacher, T. Kofler, M. Assadian, A. Maseli, J. Todd, J. Estis, M. Risch, L. Risch, D. Conen, Relationships of iron metabolism with insulin resistance and glucose levels in young and healthy adults. Eur. J. Intern. Med. 32, 31–37 (2016)CrossRefPubMed P. Krisai, S. Leib, S. Aeschbacher, T. Kofler, M. Assadian, A. Maseli, J. Todd, J. Estis, M. Risch, L. Risch, D. Conen, Relationships of iron metabolism with insulin resistance and glucose levels in young and healthy adults. Eur. J. Intern. Med. 32, 31–37 (2016)CrossRefPubMed
34.
Zurück zum Zitat C.I. Cook, B.P. Yu, Iron accumulation in aging: modulation by dietary restriction. Mech. Ageing Dev. 102, 1–13 (1998)CrossRefPubMed C.I. Cook, B.P. Yu, Iron accumulation in aging: modulation by dietary restriction. Mech. Ageing Dev. 102, 1–13 (1998)CrossRefPubMed
35.
Zurück zum Zitat C.E. Hughes, T.K. Coody, M.Y. Jeong, J.A. Berg, D.R. Winge, A.L. Hughes, Cysteine toxicity drives age-related mitochondrial decline by altering iron homeostasis. Cell 180, 296–310 (2020)CrossRefPubMedPubMedCentral C.E. Hughes, T.K. Coody, M.Y. Jeong, J.A. Berg, D.R. Winge, A.L. Hughes, Cysteine toxicity drives age-related mitochondrial decline by altering iron homeostasis. Cell 180, 296–310 (2020)CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat E.K. Batchelor, P. Kapitsinou, P.E. Pergola, C.P. Kovesdy, D.I. Jalal, Iron deficiency in chronic kidney disease: updates on pathophysiology, diagnosis, and treatment. J. Am. Soc. Nephrol. 31, 456–468 (2020)CrossRefPubMedPubMedCentral E.K. Batchelor, P. Kapitsinou, P.E. Pergola, C.P. Kovesdy, D.I. Jalal, Iron deficiency in chronic kidney disease: updates on pathophysiology, diagnosis, and treatment. J. Am. Soc. Nephrol. 31, 456–468 (2020)CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat S.T. Lugg, A. Scott, D. Parekh, B. Naidu, D.R. Thickett, Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease. Thorax 77, 94–101 (2022)CrossRefPubMed S.T. Lugg, A. Scott, D. Parekh, B. Naidu, D.R. Thickett, Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease. Thorax 77, 94–101 (2022)CrossRefPubMed
39.
Zurück zum Zitat A. Sampilvanjil, T. Karasawa, N. Yamada, T. Komada, T. Higashi, C. Baatarjav, S. Watanabe, R. Kamata, N. Ohno, M. Takahashi, Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells. Am. J. Physiol-Heart C 318, H508–H518 (2020)CrossRef A. Sampilvanjil, T. Karasawa, N. Yamada, T. Komada, T. Higashi, C. Baatarjav, S. Watanabe, R. Kamata, N. Ohno, M. Takahashi, Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells. Am. J. Physiol-Heart C 318, H508–H518 (2020)CrossRef
40.
Zurück zum Zitat M. Takahashi, K. Mizumura, Y. Gon, T. Shimizu, Y. Kozu, S. Shikano, Y. Iida, M. Hikichi, S. Okamoto, K. Tsuya, A. Fukuda, S. Yamada, K. Soda, S. Hashimoto, S. Maruoka, Iron-dependent mitochondrial dysfunction contributes to the pathogenesis of pulmonary fibrosis. Front. Pharmacol. 12, 643980 (2021)CrossRefPubMed M. Takahashi, K. Mizumura, Y. Gon, T. Shimizu, Y. Kozu, S. Shikano, Y. Iida, M. Hikichi, S. Okamoto, K. Tsuya, A. Fukuda, S. Yamada, K. Soda, S. Hashimoto, S. Maruoka, Iron-dependent mitochondrial dysfunction contributes to the pathogenesis of pulmonary fibrosis. Front. Pharmacol. 12, 643980 (2021)CrossRefPubMed
Metadaten
Titel
Association of dietary iron intake with diabetic kidney disease among individuals with diabetes
verfasst von
Yichuan Wu
Manlu Xiao
Jiaqi Chen
Yuan Tao
Aomiao Chen
Huanjia Lin
Ying Xu
Linna Li
Hongxia Jia
Yaoming Xue
Yijie Jia
Zongji Zheng
Publikationsdatum
17.05.2024
Verlag
Springer US
Erschienen in
Endocrine
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-024-03819-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.